ArticleBMC gastroenterology2025
Percutaneous endoscopy in the management of intra-abdominal complex disorders.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
BACKGROUND AND
aimsIntra-abdominal complex disorders pose significant challenges to clinicians due to their intricate nature and diagnostic uncertainties. This study aims to comprehensively evaluate the feasibility, safety, and efficacy of percutaneous endoscopy in the management of such conditions.
methodsA retrospective analysis was conducted on the clinical data of 37 patients diagnosed with intra-abdominal complex disorders who underwent percutaneous endoscopic examination and treatment at Mianyang 404 Hospital in Sichuan, China, between January 2016 and October 2024. The primary outcome was technical success. Secondary outcomes included clinical success, operation duration, length of postoperative hospital stay, adverse events, and medical costs.
resultsAll 37 patients successfully completed the percutaneous endoscopic procedure. Clinical success, with accurate diagnosis, was achieved in 34 cases (91.9%). Among these patients, 16 cases were peritoneal tuberculosis, 11 cases were intestinal adhesions (9 of which underwent endoscopic adhesiolysis and showed symptom alleviation during follow - up, with complete resolution in all cases), and 7 cases were malignant peritoneal tumors. The median procedure time was 50 min (ranging from 40 to 79 min), and the median length of postoperative hospital stay was 7 days (ranging from 5 to 12.5 days). No cases of postoperative bleeding, perforation, or organ injury were observed. The median medical cost during the entire hospitalization was 1528 USD (ranging from 1236 to 1806 USD).
conclusionsPercutaneous endoscopy is a safe and effective diagnostic tool for intra-abdominal complex disorders, offering high diagnostic accuracy and minimal complications. This technique represents a valuable and promising option for clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.